Company: INV
Filing Date: 2025-05-09
Form Type: 424B3
Source: 0001628280-25-024239
Chunk: 74

Company: Innventure, Inc.
Filing Date: 2025-05-09
Form: 424B3
Chunk 74
---
quity compensation plans(excluding securitiesreflected incolumn (a))(3)(c) |
| Equity compensation plans approved bysecurity holders............................................     |     |                                                                                     3,878,195 |     |                                                                         $12.20 |     |                                                                                                                                  7,144,699 |
| Equity compensation plans not approved bysecurity holder............................................. |     |                                                                                             — |     |                                                                              — |     |                                                                                                                                          — |
| TOTAL............................................................                                     |     |                                                                                     3,878,195 |     |                                                                         $12.20 |     |                                                                                                                                  7,144,699 |

_____________________________ (1) Reflects options, restricted stock units and Accelsius SARs outstanding under the 2024 Plan. Each Accelsius SAR represents the right of the holder to receive a number of shares of Common Stock with a value equal to the appreciation in the value of a Class A Common Unit of Accelsius over a base price of $12.175 (such appreciation in value, the “spread”). We calculated the number of shares of Common Stock covered by the Accelsius SARs for purposes of this column (a) by determining the aggregate spread and dividing it by the fair market value of a share of Common Stock all as of December 31, 2024. (2) The weighted-average exercise price relates to outstanding stock options only. The Company’s restricted stock unit awards have no exercise price. The Accelsius SARs have a base price of $12.175, but such base price relates to Class A Common Units of Accelsius, not shares of Common Stock, and is already accounted for in the calculation of the number of shares of Common Stock covered by the Accelsius SARs included in column (a) as described in footnote 1 (and for the foregoing reasons is not reflected in this column (b)). (3) As of December 31, 2024, consists of the shares available for future issuance under the 2024 Plan, all of which may be issued for awards other than options, warrants or rights (such as restricted stock). In general, the aggregate share limit under the 2024 Plan will be automatically increased on the first day of each fiscal year, until 2034, by an amount equal to the lesser of (a) 3% of the shares of the Company’s Common Stock outstanding on the last day of the immediately preceding fiscal year and (b) such smaller number of shares as determined by the Board of Directors of the Company.